DESCRIPTION – Use of this protection is increasing, but condom use is decreasing and the disease is circulating.
Although we are still unable to cure patients infected with HIV, we still have more diversified means to prevent the disease, more than forty years after the first cases were identified in France. The latest is PrEP (pre-exposure prophylaxis), sometimes referred to as the “anti-AIDS pill”. It was approved for the first time in France in 2016 and is gradually finding its place with more than 42,000 users at the start of 2022. But despite the progress in certain particularly vulnerable groups, it is slow to affect the dynamics of new cases.
The treatment consists of taking PrEP, which combines two antiretroviral agents (Truvada or generic), before a situation where there is a risk of contamination, to block the transmission of the virus. The treatment can be taken on an ad hoc basis or continuously if the lifestyle requires it (frequently changing partners, sex workers, etc.). Male homosexuals, who are one of the most at-risk groups (43% of new cases)…
This article is for subscribers only. You have 80% left to discover.
Pushing back the boundaries of science is also freedom.
Continue reading your article for €0.99 for the first month
Already subscribed? sign in
.